Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

"Depression, now recognized as a significant source of disability across the globe, is something many of us will be familiar with. This book explores the way people have discussed depression and examines how scientific understanding has led to ways to better appreciate and treat the condition. Through evaluations of contemporary research and literature, this book examines how depression has been depicted throughout history and presents an up-to-date account of how a diagnosis is made. Offering a narrative steeped in cognitive neuropsychology and emotion regulation, chapters explore the different theories behind current explanations of why depression develops and how this understanding drives the different ways to treat and manage the condition. It presents a holistic approach that considers depression in the context of physical health and how it impacts across the lifespan. This book is an essential read for practicing and trainee clinical psychologists, but its accessible and readable style will appeal to a broader audience of those looking to further understand depression"--

Depression, Mental --- Depression, Mental

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

A collection of fifty-four free-verse poems revolving around the interiority of melancholia, ranging from chaotic dyads and wearisome days to gut-wrenching despair. Birds have hollow bones, continually flying and falling from highs to lows, and therein lies the inspiration behind both the title and the content. The poems touch the spectrums of stark blacks and whites, with bleak and unrelentingly graphic depictions of the pain, loneliness, and emptiness of mental illness. For those who know it, the writing will ring only too true, for those who know of it, the words are a vicarious immersion in the depths of the human psyche. This is an expose of the intensely personal world of melancholia.

Depression, Mental.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

OBJECTIVE: To review the benefits and harms of screening and treatment for depression, anxiety, and suicide risk, and the accuracy of instruments to detect these conditions among primary care patients. DATA SOURCES: MEDLINE, PsychINFO, the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews through September 9, 2022, bridging from prior USPSTF reviews or other relevant reviews. Eligible studies included in the prior reviews were also included. We conducted ongoing surveillance for relevant literature through November 25, 2022. STUDY SELECTION: We reviewed 23,497 abstracts and assessed 1237 full-text articles against a priori inclusion criteria. We included English language studies of screening or treatment (compared to control conditions), or test accuracy of a priori selected screening instruments. Primary studies of screening and test accuracy were limited to primary care populations, as were primary studies of anxiety treatment. Primary studies of suicide prevention treatment that recruited from non-acute outpatient settings were included. Included study design varied by condition and key question; primary trials and test accuracy studies were used for smaller evidence bases, and existing systematic reviews (ESR) were used for large, mature bodies of literature. Observational studies and ESRs of observational studies were included for harms of pharmacotherapy. Critical appraisal was completed independently by two investigators for primary research. ESRs were appraised by a single reviewer and confirmed by a second reviewer if minimum quality standards were not met. Data were extracted from studies by one reviewer and checked by a second. DATA ANALYSIS: Where primary research evidence was sufficient for pooling, we conducted random effects meta-analysis using the DerSimonian & Laird or restricted maximum likelihood method with the Knapp-Hartung correction for a small number of studies. Where possible, subgroup analysis and meta-regression were used to explore effect modification. Pooled results from ESRs were presented in tables and forest plots. RESULTS: 185 studies (86 ESRs and 99 primary studies) were included, covering an estimated 13 million persons, across all conditions and key questions. Depression screening interventions, many of which included additional intervention components, were associated with a lower prevalence of depression or clinically important depressive symptomatology after six to twelve months (OR, 0.60 [95% CI, 0.50 to 0.73]; 8 RCTs [n=10,244]; I2=0%). Several instruments demonstrated adequate test accuracy (e.g., sensitivity 0.82 [95% CI, 0.76 to 0.86], specificity 0.87 [95 % CI, 0.84 to 0.89] for the patient health questionnaire (PHQ)-2 followed by the full PHQ-9 if the PHQ-2 is positive), and a large body of evidence supported benefits of psychological and pharmacologic treatment of depression. A pooled estimate from trials used for FDA approval data suggested a very small increase in the absolute risk of a suicide attempt with second generation antidepressants (OR, 1.53 [1.09 to 2.15]; N= 40,857; 0.7% of antidepressants users had a suicide attempt vs 0.3% of placebo users; median followup, 8 weeks). Two screening studies found no benefit for screening for anxiety. Among test accuracy studies, only the GAD-2 and GAD-7 were reported by more than one study and demonstrated adequate accuracy for detecting generalized anxiety disorder (e.g., sensitivity 0.84 [95% CI, 0.74 to 0.94], specificity 0.87 [95 % CI, 0.80 to 0.93] for the GAD-7 at a cutoff of 9). Evidence was limited for other instruments and other anxiety disorders. A large body of both primary and ESR evidence supports the benefit of treatment for anxiety. One RCT (n=443) of a suicide risk screening intervention found no reduction in suicidal ideation after two weeks; three studies of suicide risk test accuracy were included with no replication of any instrument; and suicide prevention studies did not demonstrate an improvement over usual care, and one large (n=18,883) trial found an increased risk of suicide attempts associated with a low-intensity online intervention in addition to usual mental health care, compared with usual mental health care alone. LIMITATIONS: Suicide prevention treatment studies typically used usual or optimized specialty mental health care as control groups, so could be considered comparative effectiveness. Limiting the examination of anxiety screening instruments to prespecified a priori instruments may have excluded some relevant studies. The use of ESRs may have limited our ability to examine effects in some specific patient populations. CONCLUSIONS: Both direct and indirect evidence support depression screening in primary care settings, including during pregnancy and postpartum. While evidence is insufficient to draw conclusions about the benefits or harms of anxiety screening interventions, there is clear evidence that treatment for anxiety is beneficial, and more limited evidence indicating acceptable accuracy of some anxiety screening instruments to detect generalized anxiety disorder. There are numerous important gaps in the evidence for suicide risk screening in primary care settings.

Depression, Mental --- Diagnosis.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Gwendoline Smith, a psychologist and bestselling author, provides an insightful exploration of depression and its various manifestations across different demographics, including postnatal depression and depression in children, teens, and older adults. The book aims to demystify mental illness by educating readers about the differences between temporary sadness and clinical depression, and offers guidance on available treatments. Smith addresses the societal pressure to be perpetually happy and the stigma surrounding mental health, advocating for understanding and kindness. The book is intended for those experiencing depression, their families, and anyone interested in mental health, offering both practical advice and a call to demystify and destigmatize mental illness.

Depression, Mental. --- Mental illness.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book by Fiona Thomas offers a candid exploration of mental health challenges in the digital age. Through her personal experiences, Thomas discusses the pressures of societal expectations and the impact of social media on mental well-being. Diagnosed with depression in 2012, she turned to blogging, which eventually led to anxiety due to her deep involvement in the online world. As an advocate for technology as a tool for communication, she shares insights on managing mental illness and building supportive communities online. The book serves as a guide for individuals navigating similar struggles, emphasizing the importance of pacing oneself while pursuing dreams. It aims to provide comfort and understanding, particularly for those affected by the demands of modern life.

Mental health --- Depression, Mental